CoverSelf Secures $4.8M to Reinvent Healthcare Claims and Payment Accuracy as It Expands in the US

The exponential growth of costs in healthcare remains a hotly debated and ever-evolving problem around the world. Over $4.1 trillion is spent on healthcare every year in the US alone, with administrative spending accounting for approximately one-quarter of the total amount. CoverSelf, a cloud platform for healthcare claims and payment integrity, is today announcing a $4.8m seed funding round to help reduce claims inaccuracies and reduce admin waste. The funding round was led by BEENEXT and 3one4 Capital.

One of the long-standing critical challenges that the US healthcare claims and payment integrity has faced is the lack of an open system that allows untethered collaboration between and among payers, vendors, and providers, without data and workflow silos and “black box” constraints. The CoverSelf platform empowers all stakeholders in the healthcare payment integrity and revenue cycle ecosystems with faster, easier, and more accurate processes, as well as faster innovation and releases. This plugs revenue leakages and eventually reduces healthcare costs by a substantial margin.

Rajasekhar Maddireddy, Founder of CoverSelf. said:

“The current claims integrity systems are very complex, and the deployed technologies are antiquated. Significant software innovation is needed to address the broken system that is currently creating out-of-control healthcare costs and waste. The cobbled-together software solutions result in scattered data and the inability to make real-time business decisions. Administrative complexity costs billions annually, an open and collaborative platform can significantly reduce the repetitive administrative costs.”

Founded in 2021, CoverSelf is a one-of-a-kind democratized, open and transparent healthcare platform, built by a team of highly experienced healthcare technology and payment integrity visionaries. CoverSelf has created a collaborative and comprehensive SaaS platform for all stakeholders, purpose-built for healthcare claims and payment integrity, providing a solid foundation for innovation while removing administrative waste and duplication of efforts. The company’s mission is to enable healthcare claims to be paid accurately, quickly, and conclusively. The platform enables a generational architectural shift that adapts to the dynamic nature of healthcare and empowers users without technical and external dependencies as the industry evolves.

Coverself Secures $4.8M
Coverself Team: Addressing The Complexity In Healthcare Payments System

“We have spent over two decades working hands-on in the claims accuracy and payment integrity sector and we believe that when everyone has the data, payment and reimbursement guidelines, and updated data sets they need to process clean claims on the first pass. However the payment models are becoming more complicated and the pace of change is increasing, creating additional challenges for stakeholders, who in turn are finding it more difficult than ever to understand the increasing complexity. Our efforts are driven towards leveraging our extensive experience to reduce complexity and administrative costs by building a unified healthcare dedicated platform” said Raghavendra Pawar, Founder of CoverSelf.

CoverSelf will use this funding round building out their platform and scaling the company operations as well as growing the sales, product and technology teams.

“Administrative spends are a major driver of overall healthcare costs. CoverSelf’s payment integrity solution is designed to be easy to implement and maintain, both under-appreciated features given the dynamic nature of healthcare. Raj and Raghav have leveraged years of experience to provide fresh perspective to the problem, and we are excited to be a part of their mission to simplify healthcare claims processing,” said Sonal Saldanha, VP, Investments 3one4 Capital.

Dirk Van Quaquebeke, Managing Partner at BEENEXT, added: “We are very excited to partner with team CoverSelf targeting the U$4.1 trillion US healthcare industry. Estimated cost of waste in the US healthcare system is approximately 25% of total health care spending. Claims and payments integrity, i.e., incorrect billing or fraud, alone accounts for over US$100bn of the problem. Now, anyone ever having worked in the US healthcare system, understands its massive complexity. We believe team CoverSelf has assembled a uniquely qualified team to abstract this away and improve healthcare outcomes at reduced prices for patients in the US.”

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The groundbreaking ColoSeal System™ enables minimally invasive colorectal tumor removal, eliminating the need for 2 open surgeries in today's standard of care notes Savage Medical.
Alto Neuroscience advises the funds will be used to support ongoing and planned late-stage clinical development of CNS product candidates with four Phase 2 readouts expected across the next 12-18 month
Micron Biomedical has received this grant from the Bill & Melinda Gates Foundation to fund mass production of needle-free vaccines utilizing Micron technology to expand the accessibility of measles-rubella vaccine in developing countries
Ann Lin, co-founder and CEO of Cromatic said, "Outsourcing R&D is one of the most powerful ways for innovative biotech companies to get off the ground. While founders of tech giants like Apple and Google could build their products in garages with minimal resources, founders in biotech are confronted with the capital expense of lab space and equipment and the lengthy process of building the right team before they can even test their ideas. That’s why we are building the most powerful R&D outsourcing platform for biotechs, so that scientists will have clarity, confidence and choice when evaluating and managing their service providers. Ultimately, we want to enable biotech companies to start in garages, just like tech giants.”
The financing will support a substantial production capacity increase for the unique MIMIX™ hydrophilic biomaterial vascular access devices developed by AVI, which are designed to evade the foreign body reaction by mimicking the human body’s natural chemistry, as well as further research into the potential for MIMIX to lower catheter infection rates, and expansion of AVI’s product portfolio notes Access Vascular.

By using this website you agree to accept Medical Device News Magazine Privacy Policy